Issue: Vol. 2, No. 12, June 30, 2015

Go Back to Medtech Strategist Issue Archive
Table of Contents – The MedTech Strategist, Vol. 2, No. 12, June 30, 2015 (40 Pages):
- Perspective: “Specialty Drug Pricing Pushback: Is this the Canary in the Mineshaft for Medtech?” by David Cassak
- Under the Lens: “Elixir Medical’s Contrarian Play in Cardiology: Go Bioresorbable or Go Home,” by Stephen Levin
- Market Snapshot: “Cartilage Repair: Next-Gen Products Tackle the Challenge,” by Mary Thompson
- Health Economics: “The Specialty Drug Price Debate: Should Medtech Be Worried?” by David Cassak
- Medtech Financing: “Half-Year Financing Recap: Crossover Investors Boost Device/Dx Financing; IPO Exits Trump M&A,” by Wendy Diller
- Start-Ups to Watch: “Autonomic Technologies: Neurostimulation Alleviates Intractable Headache Pain,” by Wendy Diller
- Start-Ups to Watch: “Renephra: Home-Based Fluid Removal for Fluid Overload and Chronic Edema,” by Mary Stuart
- Start-Ups to Watch: “Sandstone Diagnostics: A Home-Based Male Fertility Test Becomes a Health Tracker,” by Mary Stuart
Articles in This Issue
“Perspective: Specialty Drug Pricing Pushback: Is this the Canary in the Mineshaft for Medtech?” by David Cassak
Article Categories:Biopharma/Biomaterials · Oncology · Perspective & Commentary
“Under the Lens: Elixir Medical’s Contrarian Play in Cardiology: Go Bioresorbable or Go Home,” by Stephen Levin
Article Categories:Biopharma/Biomaterials · Oncology · Perspective & Commentary
“Market Snapshot: Cartilage Repair: Next-Gen Products Tackle the Challenge,” by Mary Thompson
Article Categories:Biopharma/Biomaterials · Oncology · Perspective & Commentary
“Health Economics: The Specialty Drug Price Debate: Should Medtech Be Worried?” by David Cassak
Article Categories:Biopharma/Biomaterials · Oncology · Perspective & Commentary
“Medtech Financing: Half-Year Financing Recap: Crossover Investors Boost Device/Dx Financing; IPO Exits Trump M&A,” by Wendy Diller
Article Categories:Biopharma/Biomaterials · Oncology · Perspective & Commentary
“Start-Ups to Watch: Autonomic Technologies: Neurostimulation Alleviates Intractable Headache Pain,” by Wendy Diller
Article Categories:Biopharma/Biomaterials · Oncology · Perspective & Commentary